ADVERTISEMENT

Habit Reversal Training a Valid Drug Alternative for Tics

Author and Disclosure Information

A PSYCHOPHARMACOLOGY UPDATE

Dr. McCracken said he is an adviser to BioMarin Pharmaceutical Inc., and receives research funding from Bristol-Myers Squibb and Seaside Pharmaceutical.